Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by Inclisiran
Laurien E. Zijlstra, Stella Trompet, Simon P. Mooijaart, Marjolijn van Buren, J. Wouter Jukema
Topics & Concepts
MedicineDyslipidemiaKidney diseaseInternal medicineCardiologyGuidelinePCSK9Heart failureDiseaseRisk factorMetabolic syndromeCholesterolIntensive care medicineLipoproteinPathologyObesityLDL receptorLipoproteins and Cardiovascular HealthHealth Systems, Economic Evaluations, Quality of LifeDiabetes, Cardiovascular Risks, and Lipoproteins